Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor

By Omar Aadilah   Jovanovic Katarina   Da Costa Dias Bianca   Gonsalves Danielle   Moodley Kiashanee   Caveney Robert   Mbazima Vusi   Weiss Stefan FT  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

90-kDa S6 kinase is insufficient or not involved in the activation of glycogen synthase induced by insulin

By Yasui K.   Niki I.   Hidaka H.  

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 317-323

Elsevier

Access to resources Recommend Favorite

EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data

By  

Current Bioactive Compounds, Vol. 7, Iss. 1, 2011-01 ,pp. : 3-7

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of a Porphyromonas gingivalis Colonizing Factor between Actinomyces viscosus ATCC 19246 by Monoclonal Antibodies against Recombinant 40-kDa Outer-Membrane Protein

By Saito S.   Hiratsuka K.   Hayakawa M.   Takiguchi H.   Abiko Y.  

General Pharmacology, Vol. 28, Iss. 5, 1997-05 ,pp. : 675-680

Elsevier

Access to resources Recommend Favorite

Peginterferon-α_2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J   Papatheodoridis George V  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite